PFE241213C19000
- 0.00
- 0.000.00%
Pfizer Newsroom
Riot Shares Jump 13% as Activist Starboard Takes Stake in Bitcoin-Miner
Pfizer Boost Quarter Dividend by 2.4% to 43c
Express News | Pfizer Inc - Increases Quarterly Dividend to $0.43 per Share
Press Release: Pfizer Declares First-Quarter 2025 Dividend
Express News | Pfizer Declares First-Quarter 2025 Dividend
Pfizer Options Spot-On: On December 12th, 172.12K Contracts Were Traded, With 3.65 Million Open Interest
Thursday Ends in Index Declines | Wall Street Today
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Are Pfizer Inc.'s (NYSE:PFE) Mixed Financials Driving The Negative Sentiment?
Pfizer Announces Results From PATINA Trial
Express News | Pfizer Inc - Overall Survival Data Not yet Mature
Pfizer's IBRANCE in Combination With Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients With HR+, HER2+ Metastatic Breast Cancer
Express News | Pfizer’s Ibrance® in Combination With Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 Patina Study in Patients With Hr+, Her2+ Metastatic Breast Cancer
A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $28 to $33
Today's Analyst Rating | Citi Cuts Its Price Target Cut on Johnson & Johnson to $175, Deutsche Bank Upgrades Coca-Cola to Buy
Pfizer (PFE) Gets a Hold From J.P. Morgan
Cautious Outlook: Pfizer's EPS Downgrade and Conservative Guidance Prompt Hold Rating
Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know